6-100512904-T-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4BS2
The NM_006828.4(ASCC3):āc.6090A>Cā(p.Leu2030Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000157 in 1,461,404 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006828.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASCC3 | NM_006828.4 | c.6090A>C | p.Leu2030Phe | missense_variant | 40/42 | ENST00000369162.7 | NP_006819.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASCC3 | ENST00000369162.7 | c.6090A>C | p.Leu2030Phe | missense_variant | 40/42 | 5 | NM_006828.4 | ENSP00000358159.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250912Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135628
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461404Hom.: 1 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727004
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 07, 2018 | The L2030F variant in the ASCC3 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The L2030F variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The L2030F variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Leucine are tolerated across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. As an alternate mechanism, splice predictor models suggest that L2030F may enhance the cryptic splicing acceptor site in exon 40, which may result in abnormal gene splicing. We interpret L2030F as a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at